Pfizer’s Omicron Vaccine : A Case of Too Late the Hero
Pfizer announced that a coronavirus vaccine specifically formulated to combat the Omicron variant will be ready by March but professionals fear it’s too late — everyone will become infected before they become available. Pfizer CEO Albert Bourla said the Omicron vaccine they created alongside BioNTech, aims to prevent Omicron and other variants from spreading but will be ready for distribution by spring. Experts think that had the vaccine been available in December, it might have prevented the highly contagious and transmissible variant to spread as fast as it did.
In early January, the CDC reported that over 95% of new COVID cases are because of the omicron variant. Johns Hopkins reported that there were more than 307,000 new cases of the virus last Sunday and is continuing to rise exponentially.
Why Experts say Pfizer’s Omicron Vaccine will be Useless by Spring
According to a Johns Hopkins Executive Director, Dr. William Moss.of the Bloomberg School of Public Health, it is too late if to arrest the occurring omicron pandemic, although it could still be useful in different ways.
Dr. Shaun Truelove , an epidemiologist at the same school as Moss, agrees that the vaccine might not matter at all because of the highly transmissive nature of the variant. The infection is happening so quickly that everyone will be infected before the targeted vaccine gets distributed. Truelove is also a part of The Covid Scenario Modeling Hub, a group of researchers that creates coronavirus calculations.
Moss added that the booster is assumed to be very effective against the infection for a temporary time, although this information is still not concrete. The only thing that was ascertained by this occurrence is that two doses aren’t sufficient to combat against the omicron variant, while a third dose would be more effective.